The homozygous mutant genotype of the rs1979277 (SHMT1) variant was indicated to be associated with an increased risk of toxicity in a study assessing fluoropyrimidine and platinum-based therapy-induced toxicity in gastric cancer patients23. Here, SHMT1 is linked to gastric cancer.